Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species-Reference-Cited by-同舟云学术

Exploring Cluster-Dependent Antibacterial Activities and Resistance Pathways of NOSO-502 and Colistin against Enterobacter cloacae Complex Species

Published:2022-11-15 Issue:11 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Pantel Lucile¹,Guérin François²³,Serri Marine¹,Gravey François⁴⁵^ORCID,Houard Jessica¹,Maurent Kelly¹,Attwood Marie⁶,Noel Alan⁶,MacGowan Alasdair⁶,Racine Emilie¹,Cattoir Vincent²³^ORCID,Gualtieri Maxime¹^ORCID

Affiliation:

1. Nosopharm, Nîmes, France

2. CHU de Rennes, Service de Bactériologie-Hygiène Hospitalière, Rennes, France

3. Université de Rennes 1, Unité INSERM U1230 BRM, Rennes, France

4. Université de Caen Normandie, Dynamicure, INSERM U1311, CHU de Caen, Caen, France

5. CHU de Caen, service de bactériologie, Caen, France

6. Bristol Centre for Antimicrobial Research and Evaluation (BCARE), Infection Sciences, Southmead Hospital, Bristol, United Kingdom

Abstract

The Enterobacter cloacae complex (ECC) is a group of diverse environmental and clinically relevant bacterial species associated with a variety of infections in humans. ECC have emerged as one of the leading causes of nosocomial infections worldwide.

Funder

Innovative Medicines Initiative

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.00776-22

Reference51 articles.

1. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance

2. Enterobacter spp.: pathogens poised to flourish at the turn of the century

3. Reassignment of Enterobacter dissolvens to Enterobacter cloacae as E. cloacae subspecies dissolvens comb. nov. and emended description of Enterobacter asburiae and Enterobacter kobei